HCP, Inc. (NYSE:HCP) is Green Street Investors LLC’s 2nd Largest Position

Green Street Investors LLC increased its holdings in shares of HCP, Inc. (NYSE:HCP) by 2.0% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 399,100 shares of the real estate investment trust’s stock after purchasing an additional 8,000 shares during the period. HCP accounts for about 8.3% of Green Street Investors LLC’s holdings, making the stock its 2nd biggest holding. Green Street Investors LLC’s holdings in HCP were worth $14,220,000 as of its most recent filing with the Securities and Exchange Commission.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.

A number of other institutional investors have also made changes to their positions in the stock. Barrow Hanley Mewhinney & Strauss LLC boosted its position in HCP by 11.3% during the 2nd quarter. Barrow Hanley Mewhinney & Strauss LLC now owns 14,177,081 shares of the real estate investment trust’s stock worth $453,383,000 after purchasing an additional 1,441,636 shares during the period. Invesco Ltd. boosted its position in HCP by 6.6% during the 2nd quarter. Invesco Ltd. now owns 12,663,750 shares of the real estate investment trust’s stock worth $404,988,000 after purchasing an additional 788,307 shares during the period. JPMorgan Chase & Co. boosted its position in HCP by 10.1% in the 2nd quarter. JPMorgan Chase & Co. now owns 12,570,846 shares of the real estate investment trust’s stock valued at $399,752,000 after buying an additional 1,150,685 shares during the last quarter. Resolution Capital Ltd boosted its position in HCP by 11.1% in the 3rd quarter. Resolution Capital Ltd now owns 9,733,993 shares of the real estate investment trust’s stock valued at $346,822,000 after buying an additional 976,101 shares during the last quarter. Finally, Northern Trust Corp boosted its position in HCP by 9.6% in the 2nd quarter. Northern Trust Corp now owns 9,362,249 shares of the real estate investment trust’s stock valued at $299,405,000 after buying an additional 821,684 shares during the last quarter. 95.80% of the stock is owned by hedge funds and other institutional investors.

A number of research firms have weighed in on HCP. JPMorgan Chase & Co. raised shares of HCP from a “neutral” rating to an “overweight” rating and upped their price objective for the company from $35.00 to $38.00 in a research report on Tuesday, October 8th. Barclays upped their price objective on shares of HCP from $37.00 to $39.00 and gave the company an “overweight” rating in a research report on Wednesday, October 2nd. Morgan Stanley upped their price objective on shares of HCP from $32.00 to $35.00 and gave the company an “equal weight” rating in a research report on Tuesday, September 17th. KeyCorp upped their price objective on shares of HCP from $34.00 to $37.00 and gave the company an “overweight” rating in a research report on Wednesday, October 2nd. Finally, Argus raised shares of HCP from a “hold” rating to a “buy” rating in a research report on Tuesday, September 10th. Two research analysts have rated the stock with a hold rating and ten have given a buy rating to the company. The stock presently has a consensus rating of “Buy” and an average target price of $36.78.

NYSE:HCP traded down $0.89 on Friday, reaching $33.64. The stock had a trading volume of 4,003,528 shares, compared to its average volume of 2,801,829. The stock has a market cap of $17.57 billion, a P/E ratio of 18.48, a price-to-earnings-growth ratio of 6.81 and a beta of 0.22. The company has a 50-day moving average of $36.24 and a 200 day moving average of $33.42. The company has a current ratio of 0.81, a quick ratio of 0.81 and a debt-to-equity ratio of 1.01. HCP, Inc. has a 12-month low of $26.58 and a 12-month high of $37.93.

HCP (NYSE:HCP) last issued its earnings results on Wednesday, October 30th. The real estate investment trust reported ($0.09) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.43 by ($0.52). The company had revenue of $538.00 million during the quarter, compared to analyst estimates of $503.65 million. HCP had a net margin of 43.66% and a return on equity of 12.78%. The business’s revenue for the quarter was up 18.0% compared to the same quarter last year. During the same quarter last year, the company posted $0.44 EPS. On average, equities analysts predict that HCP, Inc. will post 1.75 EPS for the current year.

The business also recently announced a quarterly dividend, which will be paid on Tuesday, November 19th. Stockholders of record on Monday, November 4th will be paid a $0.37 dividend. The ex-dividend date of this dividend is Friday, November 1st. This represents a $1.48 dividend on an annualized basis and a dividend yield of 4.40%. HCP’s dividend payout ratio (DPR) is presently 81.32%.

In other news, COO Thomas Klaritch sold 35,014 shares of the company’s stock in a transaction dated Wednesday, September 4th. The shares were sold at an average price of $36.02, for a total value of $1,261,204.28. Following the sale, the chief operating officer now owns 230,529 shares in the company, valued at approximately $8,303,654.58. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Corporate insiders own 0.13% of the company’s stock.

About HCP

HCP, Inc is a fully integrated real estate investment trust (REIT) that invests in real estate serving the healthcare industry in the United States. HCP owns a large-scale portfolio primarily diversified across life science, medical office and senior housing. Recognized as a global leader in sustainability, HCP has been a publicly-traded company since 1985 and was the first healthcare REIT selected to the S&P 500 index.

Further Reading: What are Bollinger Bands?

Want to see what other hedge funds are holding HCP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCP, Inc. (NYSE:HCP).

Institutional Ownership by Quarter for HCP (NYSE:HCP)

Leave a Reply

Your email address will not be published. Required fields are marked *